Skip to main content
SpringerLink
Log in

Cancers of the Female Genital Tract

  • Chapter
  • First Online:
Managing Psychosexual Consequences in Chronic Diseases

  • 125 Accesses

Abstract

Female genital cancers consist of neoplasms with different characteristics for age of incidence, frequency, symptoms, aggressiveness, and prognosis. Each neoplasm is characterized by a specific molecular pattern that makes it particularly sensitive to chemotherapy or radiation therapy, so the combination of various therapies (surgery, chemotherapy, hormone therapy, radiotherapy, and brachytherapy) is specific for every neoplasia (Fig. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87. https://doi.org/10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. PMID: 30100160.

    Article  CAS  PubMed  Google Scholar 

  2. Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607–18. https://doi.org/10.1200/JCO.2012.48.2596.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. https://doi.org/10.1038/nature12113. Erratum in: Nature. 2013 Aug 8;500(7461):242. PMID: 23636398; PMCID: PMC3704730.

    Article  CAS  Google Scholar 

  4. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2010;19(12):3119–30. https://doi.org/10.1158/1055-9965.EPI-10-0832. Epub 2010 Oct 28. PMID: 21030602.

    Article  CAS  Google Scholar 

  5. Dondi G, Coluccelli S, De Leo A, et al. An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. A multidisciplinary approach. Int J Mol Sci. 2020;21:1–17. https://doi.org/10.3390/ijms21197188.

    Article  CAS  Google Scholar 

  6. Savelli L, Ceccarini M, Ludovisi M, Fruscella E, De Iaco PA, Salizzoni E, Mabrouk M, Manfredi R, Testa AC, Ferrandina G. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008;31(5):560–6. https://doi.org/10.1002/uog.5295. PMID: 18398926.

    Article  CAS  PubMed  Google Scholar 

  7. Bogani G, Papadia A, Buda A, et al. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: results from a multi-institutional study. Gynecol Oncol. 2021;161:122–9. https://doi.org/10.1016/j.ygyno.2021.01.008.

    Article  PubMed  Google Scholar 

  8. Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31:12–39. https://doi.org/10.1136/ijgc-2020-002230.

    Article  PubMed  Google Scholar 

  9. Bogani G, Sopracordevole F, Di Donato V, Ciavattini A, Ghelardi A, Lopez S, Simoncini T, Plotti F, Casarin J, Serati M, Pinelli C, Valenti G, Bergamini A, Gardella B, Dell’acqua A, Monti E, Vercellini P, Fischetti M, D’ippolito G, Aguzzoli L, Mandato VD, Carunchio P, Carlinfante G, Giannella L, Scaffa C, Falcone F, Borghi C, Ditto A, Malzoni M, Giannini A, Salerno MG, Liberale V, Contino B, Donfrancesco C, Desiato M, Perrone AM, Dondi G, De Iaco P, Chiappa V, Ferrero S, Sarpietro G, Matarazzo MG, Cianci A, Bosio S, Ruisi S, Guerrisi R, Brusadelli C, Mosca L, Lagana’ AS, Tinelli R, Signorelli M, De Vincenzo R, Zannoni GF, Ferrandina G, Lovati S, Petrillo M, Dessole S, Carlea A, Zullo F, Angioli R, Greggi S, Spinillo A, Ghezzi F, Colacurci N, Muzii L, Benedetti Panici P, Scambia G, Raspagliesi F. High-risk HPV-positive and -negative high-grade cervical dysplasia: analysis of 5-year outcomes. Gynecol Oncol. 2021;161(1):173–8. https://doi.org/10.1016/j.ygyno.2021.01.020. Epub 2021 Jan 26. PMID: 33514481.

    Article  PubMed  Google Scholar 

  10. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol. 2007;104(1):232–46. https://doi.org/10.1016/j.ygyno.2006.08.053. Epub 2006 Nov 3. PMID: 17084886.

    Article  PubMed  Google Scholar 

  11. Paraskevaidis E, Arbyn M, Sotiriadis A, Diakomanolis E, Martin-Hirsch P, Koliopoulos G, Makrydimas G, Tofoski J, Roukos DH. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev. 2004;30(2):205–11. https://doi.org/10.1016/j.ctrv.2003.07.008. PMID: 15023438.

    Article  PubMed  Google Scholar 

  12. Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C, ESMO Guidelines Working Group. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):27–32. https://doi.org/10.1093/annonc/mds268. PMID: 22997451.

    Article  Google Scholar 

  13. Olthof EP, van der Aa MA, Adam JA, Stalpers LJA, Wenzel HHB, van der Velden J, Mom CH. The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review. Int J Clin Oncol. 2021;26:1600. https://doi.org/10.1007/s10147-021-01980-2.

    Article  PubMed  Google Scholar 

  14. Cima S, Perrone AM, Castellucci P, Macchia G, Buwenge M, Cammelli S, Cilla S, Ferioli M, Ferrandina G, Galuppi A, Salizzoni E, Rubino D, Fanti S, De Iaco P, Morganti AG. Prognostic impact of pretreatment fluorodeoxyglucose positron emission tomography/computed tomography SUVmax in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2018;28(3):575–80. https://doi.org/10.1097/IGC.0000000000001207. PMID: 29372911.

    Article  PubMed  Google Scholar 

  15. Perrone AM, Tesei M, Ferioli M, De Terlizzi F, Della Gatta AN, Boussedra S, Dondi G, Galuppi A, Morganti AG, De Iaco P. Results of a phase I-II study on laser therapy for vaginal side effects after radiotherapy for cancer of uterine cervix or endometrium. Cancers (Basel). 2020;12(6):1639. https://doi.org/10.3390/cancers12061639. PMID: 32575821; PMCID: PMC7352893.

    Article  PubMed  Google Scholar 

  16. Perrone AM, Bovicelli A, D’Andrilli G, Borghese G, Giordano A, De Iaco P. Cervical cancer in pregnancy: analysis of the literature and innovative approaches. J Cell Physiol. 2019;234(9):14975–90. https://doi.org/10.1002/jcp.28340. Epub 2019 Feb 20. PMID: 30790275.

    Article  CAS  PubMed  Google Scholar 

  17. Colombo N, Sessa C, Bois AD, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D. ESMO–ESGO Ovarian Cancer Consensus Conference Working Group. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer 2019:ijgc-2019-000308. https://doi.org/10.1136/ijgc-2019-000308. Epub ahead of print. PMID: 31048403.

  18. Bankhead CR, Kehoe ST, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005;112(7):857–65. https://doi.org/10.1111/j.1471-0528.2005.00572.x. PMID: 15957984.

    Article  PubMed  Google Scholar 

  19. Sekine M, Nishino K, Enomoto T. BRCA genetic test and risk-reducing Salpingo-oophorectomy for hereditary breast and ovarian cancer: state-of-the-art. Cancers (Basel). 2021;13(11):2562. https://doi.org/10.3390/cancers13112562. PMID: 34071148; PMCID: PMC8197088.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J, Massingham SK, Raikou M, Kalsi JK, Woolas R, Manchanda R, Arora R, Casey L, Dawnay A, Dobbs S, Leeson S, Mould T, Seif MW, Sharma A, Williamson K, Liu Y, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Jacobs IJ, Parmar M. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182–93. https://doi.org/10.1016/S0140-6736(21)00731-5. Epub 2021 May 12. PMID: 33991479; PMCID: PMC8192829.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Timmerman D, Planchamp F, Bourne T, Landolfo C, du Bois A, Chiva L, Cibula D, Concin N, Fischerova D, Froyman W, Gallardo G, Lemley B, Loft A, Mereu L, Morice P, Querleu D, Testa C, Vergote I, Vandecaveye V, Scambia G, Fotopoulou C. ESGO/ISUOG/IOTA/ESGE consensus statement on preoperative diagnosis of ovarian tumours. Facts Views Vis Obgyn. 2021;13(2):107–30. https://doi.org/10.52054/FVVO.13.2.016. Epub 2021 Jun 10. PMID: 34107646.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Vergote I, Amant F, Kristensen G, Ehlen T, Reed NS, Casado A. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. Eur J Cancer. 2011;47(Suppl 3):S88–92. https://doi.org/10.1016/S0959-8049(11)70152-6. PMID: 21944035.

    Article  PubMed  Google Scholar 

  23. Necula D, Istrate D, Mathis J. Fertility preservation in women with early ovarian cancer. Horm Mol Biol Clin Investig. 2020;43:163. https://doi.org/10.1515/hmbci-2020-0026. PMID: 34187159.

    Article  CAS  PubMed  Google Scholar 

  24. Wilson MK, Pujade-Lauraine E, Aoki D, Mirza MR, Lorusso D, Oza AM, du Bois A, Vergote I, Reuss A, Bacon M, Friedlander M, Gallardo-Rincon D, Joly F, Chang SJ, Ferrero AM, Edmondson RJ, Wimberger P, Maenpaa J, Gaffney D, Zang R, Okamoto A, Stuart G, Ochiai K. Participants of the fifth ovarian cancer consensus conference. Fifth ovarian cancer consensus conference of the gynecologic cancer InterGroup: recurrent disease. Ann Oncol. 2017;28(4):727–32. https://doi.org/10.1093/annonc/mdw663. PMID: 27993805; PMCID: PMC6246494.

    Article  CAS  PubMed  Google Scholar 

  25. Cianci S, Tarascio M, Rosati A, Caruso S, Uccella S, Cosentino F, Scaletta G, Gueli Alletti S, Scambia G. Sexual function and quality of life of patients affected by ovarian cancer. Minerva Med. 2019;110(4):320–9. https://doi.org/10.23736/S0026-4806.19.06080-4. Epub 2019 May 6. PMID: 31081305.

    Article  PubMed  Google Scholar 

  26. Kyo S, Kato T, Nakayama K. Current concepts and practical techniques of nerve-sparing laparoscopic radical hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2016;207:80–8. https://doi.org/10.1016/j.ejogrb.2016.10.033. Epub 2016 Oct 28. PMID: 27825032.

    Article  PubMed  Google Scholar 

  27. Son JH, Chang SJ. Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer. Gland Surg. 2021;10(3):1207–11. https://doi.org/10.21037/gs-2019-ursoc-01. PMID: 33842266; PMCID: PMC8033058.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shin W, Mun J, Park SY, Lim MC. Narrative review of liver mobilization, diaphragm peritonectomy, full-thickness diaphragm resection, and reconstruction. Gland Surg. 2021;10(3):1212–7. https://doi.org/10.21037/gs-20-422. PMID: 33842267; PMCID: PMC8033081.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Bogani G, Borghi C, Ditto A, Signorelli M, Martinelli F, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Montanelli L, Di Donato V, Infantino C, Lorusso D, Raspagliesi F. Impact of surgical route in influencing the risk of lymphatic complications after ovarian cancer staging. J Minim Invasive Gynecol. 2017;24(5):739–46. https://doi.org/10.1016/j.jmig.2017.03.014. Epub 2017 Mar 24. PMID: 28347880.

    Article  PubMed  Google Scholar 

  30. Huh JW, Tanksley J, Chino J, Willett CG, Dewhirst MW. Long-term consequences of pelvic irradiation: toxicities, challenges, and therapeutic opportunities with pharmacologic Mitigators. Clin Cancer Res. 2020;26(13):3079–90. https://doi.org/10.1158/1078-0432.CCR-19-2744. Epub 2020 Feb 25. PMID: 32098770.

    Article  CAS  PubMed  Google Scholar 

  31. Vilos GA, Reyes-MuÑoz E, Riemma G, Kahramanoglu I, Lin LT, Chiofalo B, Lordelo P, Della Corte L, Vitagliano A, Valenti G. Gynecological cancers and urinary dysfunction: a comparison between endometrial cancer and other gynecological malignancies. Minerva Med. 2021;112(1):96–110. https://doi.org/10.23736/S0026-4806.20.06770-1. Epub 2020 Jul 22. PMID: 32700863.

    Article  PubMed  Google Scholar 

  32. Woopen H, Richter R, Chekerov R, Siepmann T, Ismaeel F, Sehouli J. The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO). Gynecol Oncol. 2015;138(3):735–40. https://doi.org/10.1016/j.ygyno.2015.07.007. Epub 2015 Jul 13. PMID: 26185017.

    Article  CAS  PubMed  Google Scholar 

  33. Sun B, Yeh J. Onco-fertility and personalized testing for potential for loss of ovarian reserve in patients undergoing chemotherapy: proposed next steps for development of genetic testing to predict changes in ovarian reserve. Fertil Res Pract. 2021;7(1):13. https://doi.org/10.1186/s40738-021-00105-7. PMID: 34193292; PMCID: PMC8244159.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Hay CM, et al. Sexual health as part of gynecological cancer treatment: what do patients want? Int J. Gynecoll Cancer. 2018;28(9):1737–42.

    Article  Google Scholar 

  35. Lukett T, et al. Health-related quality of life assessment in gynecological oncology: a systematic review of questionnaires and their ability to detect clinically important differences and changes. Int J. Gynecol Cancer. 2010;20(4):664–84.

    Article  Google Scholar 

  36. White ID, Tennant A, Taylor C. Assessment of sexual morbidity in gynecological follow-up: development of sexual Well-being after cervical or endometrial cancer (SWELL-CE) patient-reported outcome measure. J Sex Med. 2020;17:2005–15.

    Article  PubMed  Google Scholar 

  37. Jonsdottir JI, et al. The efficacy of a couple intervention based on sexuality and intimacy among women in the treatment of active cancer: a quasi-experimental study. Eur J Oncol Nurs. 2021;52:101975.

    Article  PubMed  Google Scholar 

  38. Abbott-Anderson K, et al. Adjust to sex and intimacy: gynecological cancer survivors share their relationships with partners. Aging Women. 2020;32:329.

    Article  Google Scholar 

  39. Abbott-Anderson K, et al. Sexual concerns of gynecological cancer survivors: development of the gynecological sexual concerns-cancer questionnaire. Master’s thesis, 2020.

    Google Scholar 

  40. Albers LF, et al. Sexual health needs: how do breast cancer patients and their partners want information? J Marital Sex Ther. 2020;46:205.

    Article  CAS  Google Scholar 

  41. Sailors MH, et al. Validation of the MD Anderson Symptom Inventory (MDASI) for use in ovarian cancer patients. Gynecol Oncol. 2013;130(2):323–8.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Fadol A, Mendoza T, Gning I, Kernicki J, Symes L, Cleeland CS, et al. MDASI-HF psychometric testing: a symptom assessment tool for patients with cancer and concomitant heart failure. J Card Fallire. 2008;14:497–507.

    Article  Google Scholar 

  43. Wang XS, Cleeland CS, Mendoza TR, Yun YH, Wang Y, Okuyama T, et al. Impact of cultural and linguistic factors on the reporting of symptoms by cancer patients. J Natl Inst Canc. 2010;102:732–8.

    Article  Google Scholar 

  44. Simonelli LE, et al. Article navigation physical consequences and depressive symptoms in gynecological cancer survivors: meaning of life as a mediator. Ann Behav Med. 2008;35(3):275–84.

    Article  PubMed  Google Scholar 

  45. Fisherman B, Graham K, Duffecy J. Chronic diseases, disabilities and sexuality. In: McAnulty R, Burnette M, editors. Sexual function and dysfunction. Westport, CT: Praeger; 2006. p. 233–60.

    Google Scholar 

  46. Longhi EV, et al. Psychosexual approach in andrological surgical. Springer; 2019.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncologic Gynecology Unit, IRCCS—Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy

    Anna Myriam Perrone & Pierandrea De Iaco

  2. Department of Sexual Medical Center, San Raffaele Hospital, Milano, Italy

    Elena Vittoria Longhi

Authors
  1. Anna Myriam Perrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierandrea De Iaco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Vittoria Longhi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierandrea De Iaco .

Editor information

Editors and Affiliations

  1. Department of Sexual Medical Center, San Raffaele Hospital, Milano, Italy

    Elena Vittoria Longhi

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Perrone, A.M., De Iaco, P., Longhi, E.V. (2023). Cancers of the Female Genital Tract. In: Longhi, E.V. (eds) Managing Psychosexual Consequences in Chronic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-31307-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-31307-3_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-31306-6

  • Online ISBN: 978-3-031-31307-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation